Isao Shiraishi

Dr. Isao Shiraishi

Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Ōsaka, Japan
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2014 in Circulation
Verified
Journal Article
Closed access
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
KNKunihiro Nishimura
Kunihiro Nishimura
HSHeima Sakaguchi
Heima Sakaguchi
TATadaaki Abe
Tadaaki Abe
MKMasataka Kitano
Masataka Kitano
HIHajime Ichikawa
Hajime Ichikawa
Background—: Recently, infant cases of acute heart failure attributable to rupture of the mitral chordae tendineae have been reported. However, little is known about the pathogenesis and clinical course of this condition. Methods and Results—: Ninety-five children with rupture of mitral chordae tendineae were identified in nationwide surveys of Japan diagnosed from 1995 to 2013. The clinical manifestations, management strategies, and prognosis were investigated. Eighty-one (85%) patients were between 4 and 6 months (median, 5 months) of age. In 63 (66%) patients, rupture occurred during the spring or summer. The underlying conditions before rupture included Kawasaki disease (10 cases), maternally derived anti-SSA antibodies (2 cases), and infective endocarditis (1 case). Surgery was performed in 80 patients (94 operations), and the final operations included plasty of mitral chordae in 52 cases and mechanical valve replacement in 26 cases. The histopathologic examinations of the mitral valves and chordae (n=28) revealed inflammatory reactions with predominant mononuclear cell infiltration in 18 cases (64%) and increased fibrous and myxoid tissue in 11 cases (39%), suggesting that nonbacterial infectious or autoimmune endocarditis and myxoid changes are involved in the pathogenesis. Eight patients (8.4%) died before (n=6) and shortly after (n=2) the operation, and significant neurological complications persisted in 10 cases (11%). Conclusions—: Acute heart failure attributable to rupture of the mitral chordae tendineae in infants is a unique disease resulting from diverse causes. This condition should be recognized as a significant cardiovascular disorder that may cause sudden onset of cardiogenic shock and death in infants.

2 October 2014 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
THTakaya Hoashi
Takaya Hoashi
KKKoji Kagisaki
Koji Kagisaki
KKKenichi Kurosaki
Kenichi Kurosaki
MKMasataka Kitano
Masataka Kitano
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
HIHajime Ichikawa
Hajime Ichikawa

1 January 2006 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ANAyumi Niboshi
Ayumi Niboshi
MNMasashi Nishida
Masashi Nishida
TIToshiyuki Itoi
Toshiyuki Itoi
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
KHKenji Hamaoka
Kenji Hamaoka

4 July 2017 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
YHYasuhiro Hamatani
Yasuhiro Hamatani
MAMakoto Amaki
Makoto Amaki
HKHideaki Kanzaki
Hideaki Kanzaki
KYKizuku Yamashita
Kizuku Yamashita
YNYasuteru Nakashima
Yasuteru Nakashima
TAToshihisa Anzai
Toshihisa Anzai
Both surgical myectomy and percutaneous transluminal septal myocardial ablation are effective treatments for drug-refractory symptomatic hypertrophic obstructive cardiomyopathy (HOCM). However, in some cases, it is not easy to elucidate the abnormal structure of left ventricular outflow obstruction to adopt these treatments. Here, we presented a young female patient with drug-refractory symptomatic HOCM. In this case, contrast-enhanced computed tomography enabled us to assess the suitability of percutaneous transluminal septal myocardial ablation. By creating three-dimensional printed models using computed tomography data, we could also visualize intracardiac structure and simulate the surgical procedure. A multimodality assessment strategy is useful for evaluating patients complicated with drug-refractory symptomatic HOCM.

1 January 2011 in Circulation Journal
Verified
Journal Article
Open access
PDF file
HTHidemi Takata
Hidemi Takata
THTakashi Higaki
Takashi Higaki
HSHisashi Sugiyama
Hisashi Sugiyama
MKMasataka Kitano
Masataka Kitano
EYEiichi Yamamoto
Eiichi Yamamoto
EIEiichi Ishii
Eiichi Ishii
Background: Coil occlusion has been widely indicated for the closure of patent ductus arteriosus (PDA). Although many reports have shown the efficacy and safety of coil occlusion, the long-term outcome in patients remains controversial. Here, we analyzed the long-term outcome of coil occlusion in patients with PDA in Japan. Methods and Results: We collected the longitudinal data of patients who underwent coil occlusion between 1995 and 2009. A total of 310 coil occlusions were performed in 298 patients with PDA. The median minimum duct diameter was 1.4mm. Successful coil occlusion was achieved in 286 patients (96.0%), and total adverse events were seen in only 28 cases (9.0%). The median follow-up period was 50 months. The occlusion rates at 1 month, 6 months, 1 year, 2 years and 5 years were 90.1%, 94.4%, 97.4%, 97.8% and 97.8%, respectively. Patients with a large PDA (≥4mm) showed a higher rate of residual leakage than those with a small (<2mm) or moderate (2-4mm) PDA (P=0.004). Patients who underwent this procedure in the early study period also showed a higher rate of residual leakage than those in the late study period. Conclusions: Coil occlusion is an effective procedure for patients with PDA. Our data indicate that the long-term outcome is promising without any adverse events. (Circ J 2011; 75: 407-412)

13 January 2023 in Science Bulletin
Verified
Journal Article
Closed access
BXBowen Xu
Bowen Xu
QZQingyou Zhang
Qingyou Zhang
Junbao DuJunbao Du
Junbao Du
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
Hongfang JinHongfang Jin
Hongfang Jin